Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive HAART with Raltegravir and Maraviroc in Acute HIV
NCT01154673Phase 3Completed
- Sponsor
- University of Toronto
- Start
- Nov 2011
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of raltegravir, maraviroc in human immunodeficiency virus type 1 infection (HIV-1), sponsored by University of Toronto. Started Nov 2011; status: completed.
02
Drugs
raltegravirmaraviroc
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01154673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01154673.